Lubetzki J - Search Results

1

Effect of the new dopaminergic agonist CV 205-502 on plasma prolactin levels and tumour size in bromocriptine-resistant prolactinomas.

Duranteau L, Chanson P, Lavoinne A, Horlait S, Lubetzki J, Kuhn JM. Duranteau L, et al. Among authors: lubetzki j. Clin Endocrinol (Oxf). 1991 Jan;34(1):25-9. doi: 10.1111/j.1365-2265.1991.tb01731.x. Clin Endocrinol (Oxf). 1991. PMID: 1672268

2

Non-responsiveness of serum gonadotropins and testosterone to pulsatile GnRH in hemochromatosis suggesting a pituitary defect.

Duranteau L, Chanson P, Blumberg-Tick J, Thomas G, Brailly S, Lubetzki J, Schaison G, Bouchard P. Duranteau L, et al. Among authors: lubetzki j. Acta Endocrinol (Copenh). 1993 Apr;128(4):351-4. doi: 10.1530/acta.0.1280351. Acta Endocrinol (Copenh). 1993. PMID: 8498154

3

The effect of somatostatin analogue on chiasmal dysfunction from pituitary macroadenomas.

Warnet A, Timsit J, Chanson P, Guillausseau PJ, Zamfirescu F, Harris AG, Derome P, Cophignon J, Lubetzki J. Warnet A, et al. Among authors: lubetzki j. J Neurosurg. 1989 Nov;71(5 Pt 1):687-90. doi: 10.3171/jns.1989.71.5.0687. J Neurosurg. 1989. PMID: 2809722

4

Cardiovascular effects of the somatostatin analog octreotide in acromegaly.

Chanson P, Timsit J, Masquet C, Warnet A, Guillausseau PJ, Birman P, Harris AG, Lubetzki J. Chanson P, et al. Among authors: lubetzki j. Ann Intern Med. 1990 Dec 15;113(12):921-5. doi: 10.7326/0003-4819-113-12-921. Ann Intern Med. 1990. PMID: 2240917

5

[Dysthyroidism in patients treated with interferon alpha].

Chédin P, Chanson P, Duranteau L, Guillausseau PJ, Lubetzki J. Chédin P, et al. Among authors: lubetzki j. Presse Med. 1994 Nov 19;23(36):1659-63. Presse Med. 1994. PMID: 7899293 French.

6

Pituitary granuloma and pyoderma gangrenosum.

Chanson P, Timsit J, Kujas M, Violante A, Guillausseau PJ, Derome PJ, Warnet A, Lubetzki J. Chanson P, et al. Among authors: lubetzki j. J Endocrinol Invest. 1990 Sep;13(8):677-81. doi: 10.1007/BF03349595. J Endocrinol Invest. 1990. PMID: 2273210

7

The effect of subcutaneous infusion versus subcutaneous injections of a somatostatin analogue (SMS 201-995) on the diurnal GH profile in acromegaly.

Timsit J, Chanson P, Larger E, Duet M, Mosse A, Guillausseau PJ, Harris AG, Moulonguet M, Warnet A, Lubetzki J. Timsit J, et al. Among authors: lubetzki j. Acta Endocrinol (Copenh). 1987 Sep;116(1):108-12. doi: 10.1530/acta.0.1160108. Acta Endocrinol (Copenh). 1987. PMID: 2889306 Clinical Trial.

8

Remission of proteinuria following correction of hyperlipidemia in NIDDM patients with nondiabetic glomerulopathy.

Dubois D, Chanson P, Timsit J, Chauveau D, Nochy D, Guillausseau PJ, Lubetzki J. Dubois D, et al. Among authors: lubetzki j. Diabetes Care. 1994 Aug;17(8):906-8. doi: 10.2337/diacare.17.8.906. Diabetes Care. 1994. PMID: 7956642

9

Short-term continuous infusion of octreotide in acromegaly. Pharmacokinetics and prediction of the response to long-term treatment.

Timsit J, Chanson P, Harris AG, Grass P, Guillausseau PJ, Warnet A, Lubetzki J. Timsit J, et al. Among authors: lubetzki j. Horm Metab Res. 1991 Jan;23(1):48-9. doi: 10.1055/s-2007-1003610. Horm Metab Res. 1991. PMID: 2016081 No abstract available.

10

Platelet-derived growth factor (PDGF) in type 1 diabetes mellitus.

Guillausseau PJ, Dupuy E, Bryckaert MC, Timsit J, Chanson P, Tobelem G, Caen JP, Lubetzki J. Guillausseau PJ, et al. Among authors: lubetzki j. Eur J Clin Invest. 1989 Apr;19(2):172-5. doi: 10.1111/j.1365-2362.1989.tb00213.x. Eur J Clin Invest. 1989. PMID: 2525095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters